Nantahala Capital Management’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-26,692
| Closed | -$50.4K | – | 122 |
|
2024
Q1 | $50.4K | Hold |
26,692
| – | – | ﹤0.01% | 107 |
|
2023
Q4 | $70.5K | Sell |
26,692
-68
| -0.3% | -$180 | ﹤0.01% | 107 |
|
2023
Q3 | $61.5K | Hold |
26,760
| – | – | 0.01% | 108 |
|
2023
Q2 | $97.7K | Sell |
26,760
-66,537
| -71% | -$243K | 0.01% | 102 |
|
2023
Q1 | $333K | Hold |
93,297
| – | – | 0.03% | 97 |
|
2022
Q4 | $266K | Hold |
93,297
| – | – | 0.02% | 91 |
|
2022
Q3 | $208K | Sell |
93,297
-7,167
| -7% | -$16K | 0.01% | 90 |
|
2022
Q2 | $250K | Sell |
100,464
-2,143,895
| -96% | -$5.33M | 0.01% | 92 |
|
2022
Q1 | $11M | Sell |
2,244,359
-295,341
| -12% | -$1.44M | 0.48% | 30 |
|
2021
Q4 | $28.7M | Sell |
2,539,700
-31,382
| -1% | -$355K | 1.01% | 18 |
|
2021
Q3 | $37.5M | Sell |
2,571,082
-106,584
| -4% | -$1.55M | 1.18% | 14 |
|
2021
Q2 | $31.2M | Sell |
2,677,666
-26,317
| -1% | -$307K | 0.89% | 17 |
|
2021
Q1 | $33M | Buy |
2,703,983
+197,211
| +8% | +$2.41M | 0.96% | 18 |
|
2020
Q4 | $31.4M | Buy |
2,506,772
+164,556
| +7% | +$2.06M | 0.97% | 20 |
|
2020
Q3 | $35.3M | Buy |
2,342,216
+16,828
| +0.7% | +$253K | 1.08% | 11 |
|
2020
Q2 | $57M | Sell |
2,325,388
-178,452
| -7% | -$4.37M | 1.72% | 5 |
|
2020
Q1 | $35.5M | Buy |
2,503,840
+1,098,899
| +78% | +$15.6M | 1.33% | 11 |
|
2019
Q4 | $22.3M | Buy |
1,404,941
+26,743
| +2% | +$425K | 0.69% | 24 |
|
2019
Q3 | $11.6M | Hold |
1,378,198
| – | – | 0.43% | 34 |
|
2019
Q2 | $12.4M | Buy |
1,378,198
+500,100
| +57% | +$4.5M | 0.38% | 38 |
|
2019
Q1 | $6.79M | Hold |
878,098
| – | – | 0.21% | 52 |
|
2018
Q4 | $4.13M | Buy |
878,098
+25,000
| +3% | +$117K | 0.13% | 62 |
|
2018
Q3 | $7.72M | Buy |
853,098
+429,518
| +101% | +$3.89M | 0.21% | 44 |
|
2018
Q2 | $5.02M | Buy |
+423,580
| New | +$5.02M | 0.2% | 46 |
|